208 related articles for article (PubMed ID: 8153322)
21. [18Fluoro-FDG SPECT for the demonstration of hibernating myocardium: an interim account].
Alexander C; Schaefer A; Trampert L; Oberhausen E; Kirsch CM; Berberich R
Nuklearmedizin; 1997 Jun; 36(4):125-30. PubMed ID: 9289698
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography.
Worsley DF; Celler A; Adam MJ; Kwong JS; Müller NL; Coupland DB; Champion P; Finley RJ; Evans KG; Lyster DM
AJR Am J Roentgenol; 1997 Mar; 168(3):771-4. PubMed ID: 9057532
[TBL] [Abstract][Full Text] [Related]
23. Myocardial F-18 fluorodeoxyglucose imaging by SPECT.
Bax JJ; Visser FC; van Lingen A; Visser CA; Teule GJ
Clin Nucl Med; 1995 Jun; 20(6):486-90. PubMed ID: 7648727
[TBL] [Abstract][Full Text] [Related]
24. A method of correlating and merging cerebral morphology and function by a special head holder.
Kaiser HJ; Sabri O; Wagenknecht G; Lege B; Hellwig D; Büll U
Nuklearmedizin; 1994 Jun; 33(3):123-6. PubMed ID: 8090627
[TBL] [Abstract][Full Text] [Related]
25. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
Bax JJ; Wijns W
J Nucl Med; 1999 Nov; 40(11):1893-5. PubMed ID: 10565786
[No Abstract] [Full Text] [Related]
26. [Performance of a multispect 2 gamma camera for imaging 511-keV gamma rays].
Schaefer A; Oberhausen E
Nuklearmedizin; 1995 Feb; 34(1):40-6. PubMed ID: 7724363
[TBL] [Abstract][Full Text] [Related]
27. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
Bax JJ; Veening MA; Visser FC; van Lingen A; Heine RJ; Cornel JH; Visser CA
Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874
[TBL] [Abstract][Full Text] [Related]
28. Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera.
van Lingen A; Huijgens PC; Visser FC; Ossenkoppele GJ; Hoekstra OS; Martens HJ; Huitink H; Herscheid KD; Green MV; Teule GJ
Eur J Nucl Med; 1992; 19(5):315-21. PubMed ID: 1296592
[TBL] [Abstract][Full Text] [Related]
29. Myocardial viability assessment with FDG imaging: comparison of PET, SPECT, and gamma-camera coincidence detection.
Kerrou K; Toussaint JF; Froissart M; Talbot JN
J Nucl Med; 2000 Dec; 41(12):2099. PubMed ID: 11138698
[No Abstract] [Full Text] [Related]
30. Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer.
Inokuma T; Tamaki N; Torizuka T; Fujita T; Magata Y; Yonekura Y; Ohshio G; Imamura M; Konishi J
J Nucl Med; 1995 Feb; 36(2):229-35. PubMed ID: 7830119
[TBL] [Abstract][Full Text] [Related]
31. Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues.
Dilsizian V; Bacharach SL; Khin MM; Smith MF
J Nucl Cardiol; 2001; 8(1):75-88. PubMed ID: 11182712
[No Abstract] [Full Text] [Related]
32. SPECT imaging of fluorine-18.
Leichner PK; Morgan HT; Holdeman KP; Harrison KA; Valentino F; Lexa R; Kelly RF; Hawkins WG; Dalrymple GV
J Nucl Med; 1995 Aug; 36(8):1472-5. PubMed ID: 7629597
[TBL] [Abstract][Full Text] [Related]
33. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
[TBL] [Abstract][Full Text] [Related]
34. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
Tamaki N; Ohtani H; Yonekura Y; Shindo M; Nohara R; Kambara H; Kawai C; Hirata K; Ban T; Konishi J
J Cardiol; 1992; 22(2-3):283-93. PubMed ID: 1339787
[TBL] [Abstract][Full Text] [Related]
35. Myocardial [18F]FDG tomography using a conventional gamma camera and a seven pinhole collimator.
Noelpp UB; Roesler H; Ritter EP; Ledermann H
J Comput Assist Tomogr; 1994; 18(1):102-9. PubMed ID: 8282857
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of reverse redistribution on 24-hour delayed imaging of exercise thallium-201 myocardial SPECT: comparison with myocardial fluorine-18-FDG-PET imaging and left ventricular wall motion.
Ohte N; Hashimoto T; Banno T; Narita H; Kobayashi K; Akita S; Fujinami T
J Nucl Med; 1995 Jan; 36(1):86-92. PubMed ID: 7799089
[TBL] [Abstract][Full Text] [Related]
37. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
[TBL] [Abstract][Full Text] [Related]
38. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain.
Buchpiguel CA; Alavi JB; Alavi A; Kenyon LC
J Nucl Med; 1995 Jan; 36(1):159-64. PubMed ID: 7799071
[TBL] [Abstract][Full Text] [Related]
39. [PET using a coincidence camera versus ring tomography, progress or recession?].
Schwaiger M; Ziegler S
Nuklearmedizin; 1997 Sep; 36(6):3-5. PubMed ID: 9380541
[No Abstract] [Full Text] [Related]
40. Single photon emission computed tomography and positron emission tomography in cancer imaging.
Coleman RE
Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
